Study guide

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis

Key Takeaways Explain This Topic AI

APACHE II scores acute physiology from the worst values in the first 24 hours of ICU admission, plus age and chronic health points, and is used to estimate group mortality rather than to make decisions about individual patients.

The SOFA score grades six organ systems (respiratory, coagulation, liver, cardiovascular, central nervous system and renal) from 0 to 4 each, and an acute increase of 2 or more points defines sepsis-related organ dysfunction.

Enteral nutrition is preferred over parenteral nutrition in critically ill patients who can be fed through the gut, and should usually start within 24-48 hours at a low rate, increasing gradually over the first week (ESPEN guidance).

Refeeding syndrome causes hypophosphataemia, hypokalaemia and hypomagnesaemia when feeding resumes after starvation; at-risk patients start at low calorie intake with thiamine and electrolyte monitoring and replacement.

Stress ulcer prophylaxis is indicated for patients with risk factors such as coagulopathy, shock or prolonged mechanical ventilation, and pharmacological venous thromboembolism prophylaxis with low molecular weight heparin is standard unless contraindicated.

Last updated: October 2026

  • 21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis
  • Admission to Intensive Care

Intensive care is appropriate for patients who need, or are likely to need, organ support or monitoring that cannot be provided safely on a ward, and who are likely to benefit. Decisions consider:

Reversibility of the acute illness.

Chronic health and frailty (for example the Clinical Frailty Scale) and the patient's previously expressed wishes.

The burden of intensive treatment relative to the likely benefit.

Levels of care (UK terminology) are used to describe needs: level 0-1 ward care, level 2 (high dependency: single organ support or step-down), level 3 (advanced respiratory support or support of two or more organ systems).

Early warning scores (for example NEWS2, which scores respiratory rate, oxygen saturation, supplemental oxygen, temperature, systolic blood pressure, heart rate and consciousness) help identify deterioration on the ward and trigger review by critical care outreach teams.

Severity of Illness Scores

Severity scores describe the case mix of a unit, compare observed and expected mortality (the standardised mortality ratio ) and stratify patients in research. They are not designed to decide treatment for individuals .

Score Components Timing Main use

APACHE II 12 physiological variables (worst values), Glasgow Coma Scale, age points, chronic health points First 24 hours Hospital mortality prediction for groups (0-71 points)

APACHE III and IV More variables, diagnostic categories First 24 hours Refined prediction

SAPS II and SAPS 3 Physiology, age, type of admission, chronic disease (SAPS 3 at admission) First 24 hours or 1 hour (SAPS 3) Mortality prediction, widely used in Europe

  • SOFA Six organ systems scored 0-4 Daily Organ dysfunction trends; Sepsis-3 definition
  • ICNARC model UK national risk model First 24 hours Benchmarking in UK units
  • The SOFA Score
  • System Measure
  • Respiratory P a O 2 / F I O 2 P_a\text{O}_2/F_I\text{O}_2 P a ​ O 2 ​ / F I ​ O 2 ​ with respiratory support
  • Coagulation Platelet count
  • Liver Bilirubin
  • Cardiovascular Mean arterial pressure and vasopressor dose
  • Central nervous system Glasgow Coma Scale
  • Renal Creatinine or daily urine output

An acute increase of at least 2 points in a patient with suspected infection defines sepsis (Sepsis-3) and is associated with about 10% hospital mortality.

Limitations

Scores depend on accurate data collection, can be affected by treatment before admission ( lead-time bias ), perform less well in populations different from those used to develop them, and drift over time as outcomes improve ( recalibration is needed).

  • Nutrition in Critical Illness
  • Metabolic Response

Critical illness causes catabolism, insulin resistance and loss of muscle mass (up to about 1-2% per day in the first week). Early in critical illness, endogenous glucose production continues, so full feeding in the first days can lead to overfeeding .

Assessment

Risk can be assessed with tools such as the NUTRIC score or the Subjective Global Assessment ; low body mass index, recent weight loss, reduced intake and prolonged ICU stay identify patients at high risk.

Enteral versus Parenteral Nutrition

Enteral nutrition (EN) maintains gut integrity and is preferred when the gut can be used. ESPEN guidance recommends starting early EN within 24-48 hours in patients who cannot eat, at a low rate, increasing over 3-7 days.

Parenteral nutrition (PN) is reserved for patients in whom EN is contraindicated or insufficient; ESPEN suggests considering supplemental PN after about 3-7 days when targets are not met. Trials such as CALORIES and NUTRIREA-2 showed that early PN was not superior to EN and that early full enteral feeding in shock increased gastrointestinal complications.

Contraindications to EN: uncontrolled shock, uncontrolled hypoxaemia and acidosis, active upper gastrointestinal bleeding, bowel ischaemia or obstruction, high-output fistula, and abdominal compartment syndrome.

Targets

  • Component Typical target
  • Energy Measured by indirect calorimetry when available; otherwise about 20-25 kcal/kg/day, reached gradually
  • Protein About 1.3 g/kg/day, reached progressively (ESPEN)

Glucose Keep blood glucose about 6-10 mmol/L; avoid both hyperglycaemia and tight control (NICE-SUGAR showed higher mortality with targets of 4.5-6.0 mmol/L)

Practical Points

Gastric residual volumes: feeding is usually continued unless the residual is above about 500 mL in 6 hours; prokinetics (metoclopramide, erythromycin) or post-pyloric feeding help intolerance.

Aspiration prevention: head of the bed elevated 30-45°.

Diarrhoea: consider antibiotics, Clostridioides difficile , hyperosmolar drugs and feed composition.

Refeeding Syndrome

When feeding restarts after starvation, insulin release drives phosphate, potassium and magnesium into cells and increases thiamine use, causing hypophosphataemia , hypokalaemia, hypomagnesaemia, fluid retention, arrhythmias, respiratory muscle weakness and Wernicke's encephalopathy.

High-risk patients: BMI below 16 kg/m², unintentional weight loss above 15% in 3-6 months, little or no intake for more than 10 days, low electrolyte levels before feeding, or a history of alcohol misuse.

Prevention: give thiamine before and during feeding, start at about 10 kcal/kg/day (5 kcal/kg/day in extreme cases), increase slowly, and monitor and replace phosphate, potassium and magnesium.

Routine Prophylaxis: The Daily Bundle

Element Approach

Venous thromboembolism Low molecular weight heparin unless contraindicated; mechanical compression (intermittent pneumatic compression) if bleeding risk is high

Stress ulcer prophylaxis Proton pump inhibitor or H2 antagonist in patients with risk factors (coagulopathy, shock, mechanical ventilation for more than about 48 hours, high-dose steroids); SUP-ICU (2018) found no mortality benefit, and REVISE (2024) found that pantoprazole reduced clinically important bleeding in ventilated patients without changing mortality

Ventilator-associated pneumonia Head-up position, daily sedation interruption and spontaneous breathing trials, oral care, subglottic secretion drainage, avoidance of unnecessary re-intubation

  • Catheter-related infection Aseptic insertion bundles, daily review and prompt removal of unnecessary lines
  • Glycaemic control Target about 6-10 mmol/L
  • Sedation and delirium Light sedation targets, regular delirium screening
  • Mobilisation and rehabilitation Early mobilisation reduces ICU-acquired weakness
  • Pressure areas and eyes Regular repositioning, eye care in sedated patients

The mnemonic FAST HUGS BID (Feeding, Analgesia, Sedation, Thromboprophylaxis, Head-up, Ulcer prophylaxis, Glucose control, Spontaneous breathing trial, Bowel care, Indwelling catheter removal, De-escalation of antibiotics) is often used on ward rounds.

Outcomes After Critical Illness

Survivors may develop post-intensive care syndrome : physical weakness, cognitive impairment, anxiety, depression and post-traumatic stress disorder. ICU follow-up clinics, rehabilitation and patient diaries can help recovery.